Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Apixaban and Aspirin for the Prevention of Latent Bioprosthetic Valve Thrombosis After Aortic Valve Replacement Surgery: Study Protocol for a Prospective Randomized Trial

NCT06184113 is registered in ClinicalTrials.gov with Clinical Hospital Centre Zagreb as lead sponsor.

NCT NCT06184113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06184113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Apixaban and Aspirin for the Prevention of Latent Bioprosthetic Valve Thrombosis After Aortic Valve Replacement Surgery: Study Protocol for a Prospective Randomized Trial
Lead sponsor
Clinical Hospital Centre Zagreb
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2023
Completion date
December 31, 2025
Enrollment
166 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antithrombotic therapy, aortic valve replacement, bioprosthetic valve thrombosis, rapid deployment valves